Please login or register first to view this content.
Endocrine Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Insulin Lispro Injection, an Authorized Generic of Humalog, Now Available
Invokana Gets FDA’s Priority Review for CKD in T2D Indication
FDA Issues Diabetes Device Warning After Serious Adverse Event
Thyroid Hormones Not Endorsed for Subclinical Hypothyroidism
Late-Onset Type 1 Diabetes Often Misdiagnosed as Type 2
Taxing Sweetened Beverages Reduces Volume Sold
Eylea Approved for the Treatment of Diabetic Retinopathy
Fournier Gangrene Linked to SGLT2 Inhibitor Use
Low-Calorie Sweetened Drinks Do Not Cut Calories in Children
FDA Approves New Combination Therapy for Type 2 Diabetes
Liraglutide Beneficial in Pediatric Patients With Type 2 Diabetes
Risk for T2DM Increased With Use of 5α-Reductase Inhibitors
Atrasentan Tied to Lower Risk for Kidney Events in T2DM With CKD
Metformin May Cut Risk for Prematurity, Miscarriage in PCOS
Canagliflozin Lowers ESRD Risk in Diabetic Kidney Disease
Sanofi Expands Savings Program to Include More Insulin Pens, Vials at Set Monthly Price
Topical Corticosteroids Associated With Higher Risk for Type 2 Diabetes
FDA Rejects NDA for Gastroparesis Treatment Gimoti
